Spry Life

To reduce signs/symptoms, induce a major clinical response, inhibit the progression of structural damage, and improve physical function in moderately to severely active rheumatoid arthritis (RA) may be used alone or with methotrexate (MTX) or DMARDs. To reduce signs/symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2yrs of age; may be used alone or with MTX. To reduce signs/symptoms, inhibit the progression of structural damage, and improve physical function in active psoriatic arthritis it may be used alone or with DMARDs. To reduce signs and symptoms of active ankylosing spondylitis.